Chengdu Kanghong Pharmaceutical Group

Overview

See how the biggest companies compare on our leaderboards

Chengdu Kanghong Pharmaceutical Group Co., Ltd. (Chinese: 成都康弘药业集团股份有限公司) is a publicly traded pharmaceutical company based in the province of Sichuan, China.²

Calendar

Drug trials and FDA: recently

1. Apr 24, 2026Phase 2 trial completed Phase 2 trial of KH607 tablet in Postpartum Depressive Disorder: primary completion Apr 24, 2026, no results posted yet (ClinicalTrials.gov NCT07096791).³
2. Feb 9, 2026Phase 2 trial completed Phase 2 trial of KH607 tablets in Major Depressive Disorder (MDD): primary completion Feb 9, 2026, no results posted yet (ClinicalTrials.gov NCT07101120).⁴

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). Trials from ClinicalTrials.gov, as the sponsor registered them (expected dates are the sponsor's own and often move); approvals and advisory committee meetings from the FDA. The FDA does not publish its decision (PDUFA) dates. The full markets calendar

Links

• WikipediaChengdu Kanghong Pharmaceutical Group
• WikidataQ107132495